Guangdong Hybribio Biotech Co.,Ltd. 300639.SZ Stock
Guangdong Hybribio Biotech Co.,Ltd. Price Chart
Guangdong Hybribio Biotech Co.,Ltd. 300639.SZ Financial and Trading Overview
| Guangdong Hybribio Biotech Co.,Ltd. stock price | 6.52 CNY |
| Previous Close | 8.44 CNY |
| Open | 8.46 CNY |
| Bid | 8.46 CNY x 0 |
| Ask | 8.47 CNY x 0 |
| Day's Range | 8.41 - 8.53 CNY |
| 52 Week Range | 8.24 - 14.97 CNY |
| Volume | 4.39M CNY |
| Avg. Volume | 6.18M CNY |
| Market Cap | 5.5B CNY |
| Beta (5Y Monthly) | 0.372945 |
| PE Ratio (TTM) | 4.2994924 |
| EPS (TTM) | 0.61 CNY |
| Forward Dividend & Yield | 0.35 (4.19%) |
| Ex-Dividend Date | May 22, 2023 |
| 1y Target Est | N/A |
300639.SZ Valuation Measures
| Enterprise Value | 4.63B CNY |
| Trailing P/E | 4.2994924 |
| Forward P/E | 8.386139 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.2529271 |
| Price/Book (mrq) | 1.1162362 |
| Enterprise Value/Revenue | 1.055 |
| Enterprise Value/EBITDA | 2.354 |
Trading Information
Guangdong Hybribio Biotech Co.,Ltd. Stock Price History
| Beta (5Y Monthly) | 0.372945 |
| 52-Week Change | -38.81% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 14.97 CNY |
| 52 Week Low | 8.24 CNY |
| 50-Day Moving Average | 9.79 CNY |
| 200-Day Moving Average | 11.61 CNY |
300639.SZ Share Statistics
| Avg. Volume (3 month) | 6.18M CNY |
| Avg. Daily Volume (10-Days) | 4.29M CNY |
| Shares Outstanding | 649.15M |
| Float | 365.96M |
| Short Ratio | N/A |
| % Held by Insiders | 46.89% |
| % Held by Institutions | 3.45% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.233 |
| Trailing Annual Dividend Yield | 2.76% |
| 5 Year Average Dividend Yield | 117.00% |
| Payout Ratio | 0.1195 |
| Last Split Factor | 1.5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 29.42% |
| Operating Margin (ttm) | 40.72% |
| Gross Margin | 66.65% |
| EBITDA Margin | 44.84% |
Management Effectiveness
| Return on Assets (ttm) | 19.29% |
| Return on Equity (ttm) | 27.95% |
Income Statement
| Revenue (ttm) | 4.39B CNY |
| Revenue Per Share (ttm) | 6.66 CNY |
| Quarterly Revenue Growth (yoy) | -80.00000000000000000000000000000000% |
| Gross Profit (ttm) | 3.79B CNY |
| EBITDA | 1.97B CNY |
| Net Income Avi to Common (ttm) | 1.29B CNY |
| Diluted EPS (ttm) | 1.97 |
| Quarterly Earnings Growth (yoy) | -86.90% |
Balance Sheet
| Total Cash (mrq) | 1.31B CNY |
| Total Cash Per Share (mrq) | 2 CNY |
| Total Debt (mrq) | 137.83M CNY |
| Total Debt/Equity (mrq) | 2.63 CNY |
| Current Ratio (mrq) | 3.794 |
| Book Value Per Share (mrq) | 7.588 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.26B CNY |
| Levered Free Cash Flow (ttm) | 149.34M CNY |
Profile of Guangdong Hybribio Biotech Co.,Ltd.
| Country | China |
| State | N/A |
| City | Sheung Wan |
| Address | 50 Bonham Strand |
| ZIP | N/A |
| Phone | 852 2851 8029 |
| Website | https://www.hybribio.cn |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 3339 |
Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal. The company also offers STD real time PCR kits; hepatitis B virus real-time PCR kits and thalassemia genoarray diagnostic kits; hearing loss susceptibility genoarray diagnostic kits; COVID-19 real-time PCR kits; and devices/instruments, including automated nucleic acid extraction, automatic medical PCR analysis, flow-through hybridization, auto DNA extraction, and fluorescent quantitative detection systems, as well as after-sales technical service support. Its products are used in the fields of national screening, clinical, and research purposes. The company operates in the Asia Pacific, the South East Asia, the Middle East, Europe, Africa, and South America. Guangdong Hybribio Biotech Co.,Ltd. was founded in 2003 and is based in Sheung Wan, Hong Kong.
Q&A For Guangdong Hybribio Biotech Co.,Ltd. Stock
What is a current 300639.SZ stock price?
Guangdong Hybribio Biotech Co.,Ltd. 300639.SZ stock price today per share is 6.52 CNY.
How to purchase Guangdong Hybribio Biotech Co.,Ltd. stock?
You can buy 300639.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Guangdong Hybribio Biotech Co.,Ltd.?
The stock symbol or ticker of Guangdong Hybribio Biotech Co.,Ltd. is 300639.SZ.
Which industry does the Guangdong Hybribio Biotech Co.,Ltd. company belong to?
The Guangdong Hybribio Biotech Co.,Ltd. industry is Diagnostics & Research.
How many shares does Guangdong Hybribio Biotech Co.,Ltd. have in circulation?
The max supply of Guangdong Hybribio Biotech Co.,Ltd. shares is 646.5M.
What is Guangdong Hybribio Biotech Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
Guangdong Hybribio Biotech Co.,Ltd. PE Ratio is 10.68852400 now.
What was Guangdong Hybribio Biotech Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
Guangdong Hybribio Biotech Co.,Ltd. EPS is 0.61 CNY over the trailing 12 months.
Which sector does the Guangdong Hybribio Biotech Co.,Ltd. company belong to?
The Guangdong Hybribio Biotech Co.,Ltd. sector is Healthcare.